Evolus Inc is a beauty-focused company that specializes in aesthetic treatment products, with a particular emphasis on non-surgical cosmetic procedures
The company is renowned for its innovative solutions designed to enhance natural beauty, catering primarily to the needs of individuals seeking to improve their appearance through injectable treatments. Evolus aims to empower consumers with access to high-quality aesthetic products and services, fostering a positive self-image and confidence. The company's flagship offerings are aimed at the aesthetic physician market, supporting professionals in delivering effective and satisfying results for their clients.
Shares of Panbela Therapeutics, Inc. (NASDAQPBLA) fell sharply during Monday’s session after the company announced pricing of a roughly $9 million public offering. Panbela Therapeutics shares dipped 65.5% to $1.47 on Monday.
U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQSOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.
AbbVie Inc's (NYSEABBV) unwavering confidence in Botox's resilience within the aesthetics market with a commanding 68% market share remains steadfast. Despite a recent FDA petition addressing potential risks, AbbVie emphasizes its commitment to safety with existing 'black box' warnings. Amidst economic uncertainties and emerging competitors, AbbVie anticipates continued strength.
Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to Botox and similar injections.
